受强制性开放获取政策约束的文章 - Annu Joji了解详情
无法在其他位置公开访问的文章：1 篇
First‐in‐class pyrido[2,3‐d]pyrimidine‐2,4(1H,3H)‐diones against leishmaniasis and tuberculosis: Rationale, in vitro, ex vivo studies and mechanistic insights
D Ramesh, D Sarkar, A Joji, M Singh, AK Mohanty, B G. Vijayakumar, ...
Archiv der Pharmazie 355 (4), 2100440, 2022
强制性开放获取政策： Department of Science & Technology, India
可在其他位置公开访问的文章：2 篇
In silico pharmacokinetic and molecular docking studies of natural flavonoids and synthetic indole chalcones against essential proteins of SARS-CoV-2
BG Vijayakumar, D Ramesh, A Joji, T Kannan
European journal of pharmacology 886, 173448, 2020
强制性开放获取政策： Department of Science & Technology, India
Indole chalcones: Design, synthesis, in vitro and in silico evaluation against Mycobacterium tuberculosis
D Ramesh, A Joji, BG Vijayakumar, A Sethumadhavan, M Mani, T Kannan
European Journal of Medicinal Chemistry 198, 112358, 2020
强制性开放获取政策： Department of Science & Technology, India
出版信息和资助信息由计算机程序自动确定